Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| BlackRock Inc. | AAXJ iShares Trust | 13G | 33.3% | Jun 30, 2024 | 2y |
| BlackRock Inc. | TDW Tidewater Inc | 13G/A | 12.5% | Jun 30, 2024 | 2y |
| BlackRock Inc. | ATRA Atara Biotherapeutics, Inc. | 13G/A | 0% | Jun 30, 2024 | 2y |
| BlackRock Inc. | KZR Kezar Life Sciences, Inc. | 13G/A | 1.1% | Jun 30, 2024 | 2y |
| BlackRock Inc. | BCLO BlackRock ETF Trust II | 13G | 50% | Jun 30, 2024 | 2y |
| BlackRock Inc. | VCYT Veracyte, Inc. | 13G/A | 10.2% | Jun 30, 2024 | 2y |
| BlackRock Inc. | SVCO Silvaco Group, Inc. | 13G/A | 2.7% | Jun 30, 2024 | 2y |
| BlackRock Inc. | CSTL Castle Biosciences Inc | 13G/A | 11% | Jun 30, 2024 | 2y |
| BlackRock Inc. | CNTY Century Casinos Inc | 13G/A | 1.8% | Jun 30, 2024 | 2y |
| BlackRock Inc. | ACRS Aclaris Therapeutics, Inc. | 13G/A | 2.9% | Jun 30, 2024 | 2y |
| BlackRock Inc. | ELAN Elanco Animal Health Inc | 13G/A | 4.7% | Jun 30, 2024 | 2y |
| BlackRock Inc. | NDLS NOODLES & Co | 13G/A | 1.3% | Jun 30, 2024 | 2y |
| BlackRock Inc. | CVNA Carvana Co. | 13G/A | 4.2% | Jun 30, 2024 | 2y |
| BlackRock Inc. | HE Hawaiian Electric Industries Inc | 13G/A | 10.2% | Jun 30, 2024 | 2y |
| BlackRock Inc. | STOK Stoke Therapeutics, Inc. | 13G | 10.4% | Jun 30, 2024 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 19.5% | Jun 30, 2024 | 2y |
| BlackRock Inc. | TTEC TTEC Holdings, Inc. | 13G/A | 3.7% | Jun 30, 2024 | 2y |
| WELLINGTON MANAGEMENT GROUP LLP | TPG TPG Inc. | 13G | 10.16% | Jun 28, 2024 | 2y |
| SR One Capital Management, LLC | KALA KALA BIO, Inc. | 13D | 9.99% | Jun 28, 2024 | 2y |
| WELLINGTON MANAGEMENT GROUP LLP | CUBI Customers Bancorp, Inc. | 13G/A | 10.18% | Jun 28, 2024 | 2y |
| Bryan Sheffield | TBN Tamboran Resources Corp | 13D | 16.1% | Jun 28, 2024 | 2y |
| WELLINGTON MANAGEMENT GROUP LLP | SDHC Smith Douglas Homes Corp. | 13G | 12.53% | Jun 28, 2024 | 2y |
| WESTFIELD CAPITAL MANAGEMENT CO LP | MURA Mural Oncology plc Ordinary Shares | 13G/A | 4.39% | Jun 28, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | RXRX Recursion Pharmaceuticals, Inc. | 13G | 5.9% | Jun 28, 2024 | 2y |
| John Fichthorn | DMAC DiaMedica Therapeutics Inc. | 13G | 5.2% | Jun 28, 2024 | 2y |
| WELLINGTON MANAGEMENT GROUP LLP | MFA Mfa Financial, Inc. | 13G/A | 10.67% | Jun 28, 2024 | 2y |
| WELLINGTON MANAGEMENT GROUP LLP | RWT Redwood Trust Inc | 13G/A | 10.34% | Jun 28, 2024 | 2y |
| WELLINGTON MANAGEMENT GROUP LLP | MORF Morphic Holding, Inc. Common Stock | 13G/A | 11.61% | Jun 28, 2024 | 2y |
| FMR LLC | NMRA Neumora Therapeutics, Inc. | 13G | 5.4% | Jun 28, 2024 | 2y |
| COATUE MANAGEMENT LLC | HUT Hut 8 Corp. | 13G | 9.2% | Jun 28, 2024 | 2y |
| Kenneth R. Lehman | BRBS Blue Ridge Bankshares, Inc. | 13D/A | 27.2% | Jun 28, 2024 | 2y |
| Lam Chi Ming | PMA PMA Graphene Technology Group Inc. | 13D | 100% | Jun 27, 2024 | 2y |
| Liberty Energy Services LLC (f/k/a Liberty Oilfield Services LLC) | TBN Tamboran Resources Corp | 13G | 6.3% | Jun 27, 2024 | 2y |
| Ayrton Capital LLC | LUCD Lucid Diagnostics Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Ghisallo Capital Management LLC | THCP Thunder Bridge Capital Partners IV, Inc. Class A Common Stock | 13G | 10.5% | Dec 31, 2023 | 2y |
| Artal Participations S.a r.l | HOOK HOOKIPA Pharma Inc. | 13G | 5.9% | Jun 1, 2023 | 2y |
| LionGuard Capital Management Inc. | ACCS ACCESS Newswire Inc. | 13G/A | 0% | May 29, 2023 | 2y |
| North Star Investment Management Corp. | BGSF Bgsf, Inc. | 13G/A | 2.7% | Jul 5, 2024 | 2y |
| The Coca-Cola Company | COKE Coca-Cola Consolidated, Inc. | 13D/A | 24.3% | Jul 5, 2024 | 2y |
| Al Shams Investments Limited | BHR Braemar Hotels & Resorts Inc. | 13D/A | 9.8% | Jul 4, 2024 | 2y |
| Ronald S. Boreta | AASP Agassi Sports Entertainment Corp. | 13D | 34.4% | Jul 3, 2024 | 2y |
| OPKO HEALTH, INC. | WGS GeneDx Holdings Corp. | 13D/A | 13.27% | Jul 3, 2024 | 2y |
| Askew James M. | AASP Agassi Sports Entertainment Corp. | 13D | 13.7% | Jul 3, 2024 | 2y |
| Timothy A. Springer | RNAC Cartesian Therapeutics, Inc. | 13D/A | 36.3% | Jul 2, 2024 | 2y |
| JANUS HENDERSON GROUP PLC | ORKA Oruka Therapeutics, Inc. | 13G/A | 10.2% | Jul 2, 2024 | 2y |
| Jacques Patrick Supervielle | SUPV Grupo Supervielle S.A. | 13G/A | 4.2% | Jul 2, 2024 | 2y |
| BBAI Ultimate Holdings, LLC | BBAI BigBear.ai Holdings, Inc. | 13D/A | 58% | Jul 2, 2024 | 2y |
| BRIGADE CAPITAL MANAGEMENT, LP | GFR Greenfire Resources Ltd. | 13D/A | 7.8% | Jul 2, 2024 | 2y |
| BAILLIE GIFFORD & CO | GH Guardant Health, Inc. | 13G/A | 4.98% | Jun 28, 2024 | 2y |
| BAILLIE GIFFORD & CO | ALNY Alnylam Pharmaceuticals, Inc. | 13G/A | 4.77% | Jun 28, 2024 | 2y |